|

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

RECRUITINGSponsored by Chang Gung Memorial Hospital
Actively Recruiting
SponsorChang Gung Memorial Hospital
Started2023-12-12
Est. completion2026-11-30
Eligibility
Age20 Years – 75 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06221020

Summary

The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.

Eligibility

Age: 20 Years – 75 YearsHealthy volunteers accepted
Inclusion Criteria:

* Clinical diagnosis of pituitary tumors
* To sign a written informed consent form

Exclusion Criteria:

* Diagnosed with other malignant tumors
* Severe infections, such as osteomyelitis, acute inflammation at the affected site, or open wounds at the treatment area
* Pregnant women
* Coagulation disorders or those taking anticoagulant medication
* Other central nervous system disorders, alcohol addiction, other addictive drugs, or mental illness that may affect clinical assessment
* Deemed unsuitable for surgical treatment or unable to comply with clinical evaluation upon assessment

Conditions4

CancerEnhanced Recovery After SurgeryPituitary TumorPostoperative Complications

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.